Market Research Reports, Inc. has announced the addition of “US Market Report for Transcatheter Mitral Valve Repair Devices 2018 - MedCore” research report to their website www.MarketResearchReports.com
Lewes, DE -- (SBWIRE) -- 01/10/2018 -- Transcatheter heart valve repair is often referred to as percutaneous heart valve repair (PHVR). The naming conventions are also changed to account for the specific heart valve that the device is indicated for. Devices currently approved and undergoing trials are intended for use on the mitral valve and are thus labeled as transcatheter mitral valve replacement (TMVR) devices.
Abbott Laboratories' MitraClip™ is the only TMVR device approved for use by the FDA. The MitraClip™ procedure is based on the edge-to-edge surgical method of valve repair. In the MitraClip™ procedure, the steerable guide catheter is inserted into the femoral vein at the groin and provides a conduit to access the mitral valve. The clip delivery system delivers and deploys the MitraClip™, which must be carefully timed by the physician but can be adjusted if the position is not desirable. This procedure is performed while the heart is still beating, without cardiopulmonary bypass or the need for a thoracotomy or sternotomy.
The human heart contains four valves: the mitral valve, tricuspid valve, aortic valve and pulmonary valve. The mitral valve is most prone to regurgitation, which is a condition where blood is funneled back into the left atrium of the heart. Mitral regurgitation (MR) can either be caused by a congenital defect or myxomatous degeneration of the valve. Individuals with MR can suffer from atrial fibrillation, heart muscle dysfunction and even sudden death caused by cardiac arrest. In the U.S., there are just over
4 million people that may have MR, with only a minority actually diagnosed. The standard of care for MR is open surgery and/or the use of annuloplasty rings.
Spanning over 378 pages "US Market Report for Transcatheter Mitral Valve Repair Devices 2018 - MedCore" report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Portfolio, Transcatheter Mitral Valve Repair Device Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.
Please visit this link for more details: https://www.marketresearchreports.com/idata-research/us-market-report-transcatheter-mitral-valve-repair-devices-2018-medcore
Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
About Market Research Reports, Inc.
Market Research Reports® Inc. is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: http://www.marketresearchreports.com/contact